STOCK TITAN

Blue Ridge Bnksh SEC Filings

BRBS NYSE

Welcome to our dedicated page for Blue Ridge Bnksh SEC filings (Ticker: BRBS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Blue Ridge Bankshares, Inc. filings document the formal disclosures of a bank holding company for Blue Ridge Bank, National Association and BRB Financial Group, Inc. Recent Form 8-K reports furnish quarterly results, describe the termination of the OCC consent order affecting the bank subsidiary, and record capital actions involving special cash dividends, warrants and related securities terms.

The company’s proxy and current reports also cover annual meeting matters, board composition, executive transitions, compensation arrangements, equity awards, and shareholder voting items. These filings frame BRBS disclosures around community-banking operations, regulatory status, governance, capital structure, and banking, wealth management and trust-service activities.

Rhea-AI Summary

Blue Ridge Bankshares, Inc. updated its investor presentation for meetings with investors and furnished the materials as Exhibit 99.1 under Item 7.01 (Regulation FD). The materials are provided for information purposes and are being furnished, not filed.

The Company’s common stock trades on the NYSE American under the symbol BRBS.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Blue Ridge Bankshares (BRBS) reported improved profitability for Q3 2025. Net income was $5.6 million, up from $0.9 million a year ago, as lower funding costs and reduced operating expenses lifted results. Net interest income reached $21.9 million while the company recorded a $1.8 million recovery of credit losses, supporting earnings.

The balance sheet continued to streamline. Total assets were $2.50 billion versus $2.74 billion at year-end. Total deposits were $1.95 billion compared with $2.18 billion, with time deposits declining. Loans held for investment were $1.89 billion versus $2.09 billion as of December 31, 2024. Equity rose to $355.5 million, helped by an improvement in accumulated other comprehensive loss to $31.8 million from $42.5 million.

The company authorized a $15.0 million share repurchase program and bought 659,949 shares at a weighted average price of $4.16 (about $2.8 million) during the quarter. Subordinated notes declined to $14.7 million from $39.8 million, reflecting repayments. The bank remains under an OCC Consent Order but reported capital ratios above the required minimums as of September 30, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Blue Ridge Bankshares, Inc. (BRBS) announced a special cash dividend of $0.25 per share on its common stock. The dividend will be paid on November 21, 2025 to shareholders recorded as of the close of business on November 7, 2025.

This one-time payout returns cash to shareholders outside of the company’s regular dividend cycle and sets clear record and payment dates for eligibility and distribution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.09%
Tags
current report
Rhea-AI Summary

Blue Ridge Bankshares (BRBS) furnished a press release announcing financial results for the third quarter ended September 30, 2025. The release is provided as Exhibit 99.1 to this Form 8‑K under Item 2.02 and is incorporated by reference. The company’s common stock trades on NYSE American under the symbol BRBS.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
current report
-
Rhea-AI Summary

Blue Ridge Bankshares insider stock grant and holdings update. Director Hunter H. Bost received 9,245 shares of common stock on 09/08/2025 as stock in lieu of cash compensation at an indicated price of $4.17 per share. After the reported transaction the filing shows 168,496.0349 shares beneficially owned directly. The filing also discloses 18,321 shares held indirectly by a parent under power of attorney and 9,750 shares held indirectly by the William S. Bost, Jr. Trust. The newly acquired shares are noted as restricted stock subject to a vesting schedule, and the form was signed by an attorney-in-fact on 09/10/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Heather Cozart, a director of Blue Ridge Bankshares, Inc. (BRBS), reported acquiring 9,544 shares of the issuer's common stock on 09/08/2025 at a reported price of $4.17 per share. The filing states the shares were received in lieu of cash compensation and are restricted stock subject to a vesting schedule. Following the transaction, the reporting person beneficially owned 56,039 shares. The Form 4 was signed by Amanda G. Story as attorney-in-fact on 09/10/2025. The filing identifies the reporting person as a director and was filed by a single reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Julien G. Patterson, a director of Blue Ridge Bankshares, Inc. (BRBS), reported a transaction dated 09/08/2025 in which he received 9,005 shares of common stock at a reported price of $4.17 per share. The filing states these shares were received in lieu of cash compensation and are restricted subject to a vesting schedule. After the transaction, Mr. Patterson beneficially owned 309,263.9177 shares directly and held an additional 40,000 shares indirectly through the "Julien G. Patterson, Revocable Trust, dated 2/14/2023." The Form 4 was signed by Amanda G. Story, Attorney-in-Fact, on 09/10/2025. The filing was made by a single reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Insider transaction disclosure: Otis Jones, identified as a director of Blue Ridge Bankshares, Inc. (BRBS), was reported to have acquired 3,434 shares of the issuer's common stock on 09/08/2025 at a recorded price of $4.17 per share. Following this transaction, Mr. Jones beneficially owns 15,929 shares. The Form 4 states these shares were received in lieu of cash compensation and are restricted stock subject to a vesting schedule, indicating the shares are not fully transferable until vesting conditions are met. The filing was signed by an attorney-in-fact on 09/17/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Reynolds Randolph N. Jr., a director of Blue Ridge Bankshares, Inc. (BRBS), reported an internal stock award on Form 4. On 09/08/2025 he received 5,863 shares of common stock in lieu of cash compensation at an indicated per-share value of $4.17. After this award his beneficial ownership is reported as 38,575 shares, held directly. The filing states these shares are restricted and subject to a vesting schedule, and the Form 4 was signed by an attorney-in-fact on 09/10/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Blue Ridge Bankshares director Vance H. Spilman reported an acquisition of 12,230 shares of common stock on 09/08/2025 at a price of $4.17 per share. The filing shows these shares were restricted stock received in lieu of cash compensation and will vest according to a schedule. After the transaction, the reporting person beneficially owned 154,321 shares. The Form 4 was signed by Amanda G. Story as attorney-in-fact on 09/10/2025.

The disclosure is a routine insider reporting of compensation-related equity issuance rather than an open-market purchase; no derivative transactions or other material events are shown.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Blue Ridge Bnksh (BRBS) SEC filings are available on StockTitan?

StockTitan tracks 35 SEC filings for Blue Ridge Bnksh (BRBS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Blue Ridge Bnksh (BRBS)?

The most recent SEC filing for Blue Ridge Bnksh (BRBS) was filed on November 5, 2025.